Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1200
Trial Sponsor
Clinical Trial Start Date
2007
0Primary Completion Date
2011
0Study Completion Date
2011
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Dietary Supplement0
Interventional Trial Phase
Phase 30
Phase 20
Participating Facility
Official Name
Genistein Use in Postmenopausal Women With Metabolic Syndrome0
Last Updated
September 14, 2012
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Care Provider0
Outcomes Assessor0
Investigator0
Participant0
Other attributes
Intervention Treatment
genistein0
placebo0
Study summary
The purpose of this study is to determine whether the phytoestrogen genistein is effective in improving bone condition in pre-menopausal and post-menopausal women suffering for osteopenia. Since, during the study the investigators realized that at least 70% of post-menopausal recruited women suffered for metabolic syndrome (MS), we have added only in these women, as secondary outcome measures, the evaluation of markers of cardiovascular risk.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
